Stay updated with breaking news from Theravance inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Innoviva (NASDAQ:INVA – Get Rating) was downgraded by Zacks Investment Research from a “strong-buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday, Zacks.com reports. According to Zacks, “Innoviva, Inc. is focused on the development, commercialization and financial management of bio-pharmaceuticals. The company’s portfolio of respiratory assets partnered […] ....
Theravance Biopharma, Inc. Announces Strategic Actions to Focus on Respiratory Disease Portfolio prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.